Anixa Biosciences, Inc. (ANIX)
NASDAQ·Healthcare·Biotechnology
$3.28
+0.00%
Mkt Cap $99.47M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$5.83
Range $3.50 – $10.00
Implied Upside
+77.7%
Consensus $5.83 vs current $3.28
NASDAQ·Healthcare·Biotechnology
$3.28
+0.00%
Mkt Cap $99.47M
No recent rating data.
Price Target (3 analysts)
$5.83
Range $3.50 – $10.00
+77.7%
Consensus $5.83 vs current $3.28